VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VYCOR MEDICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.07+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.24M
- P/E (TTM)
- –
- Dividend yield
- –
VYCOR MEDICAL INC revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc [Member] | $401.22K | $440.44K | $403.66K | $492.10K | $481.79K | $418.52K | $437.10K | $372.84K | $387.25K | $318.56K | – | – | 95.9% | -16.7% |
| NovaVision Inc [Member] | $17.04K | $18.10K | $13.22K | $21.69K | $14.57K | $17.86K | $18.13K | $18.02K | $19.03K | $18.41K | – | – | 4.1% | +17.0% |
| Vycor Medical [Member] | – | – | – | – | – | – | $437.10K | $372.84K | $387.25K | $318.56K | $290.84K | $287.56K | – | – |
| NovaVision [Member] | – | – | – | – | – | – | $18.13K | $18.02K | $19.03K | $18.41K | $17.41K | $21.03K | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vycor Medical Inc [Member] | $94.76K | $151.12K | $76.17K | $147.39K | $192.73K | $77.49K | $129.99K | $52.69K | $98.49K | $71.89K | – | – | -50.8% |
| Corporate Segment [Member] | -$37.96K | -$57.64K | -$58.78K | -$70.61K | -$93.17K | -$53.45K | -$60.51K | -$44.61K | -$39.21K | -$39.95K | -$36.33K | -$43.99K | -59.3% |
| NovaVision Inc [Member] | -$49.95K | -$47.67K | -$53.92K | -$44.70K | -$48.42K | -$36.84K | -$50.13K | -$43.22K | -$43.10K | -$41.47K | – | – | +3.2% |
| Vycor Medical [Member] | – | – | – | – | – | – | $129.99K | $52.69K | $98.49K | $71.89K | $17.49K | $60.37K | – |
| NovaVision [Member] | – | – | – | – | – | – | -$50.13K | -$43.22K | -$43.10K | -$41.47K | -$45.22K | -$41.87K | – |
By product or service
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $416.82K | $455.71K | $414.55K | $511.95K | $496.00K | $435.98K | $454.49K | $389.48K | $405.74K | $335.93K | $306.84K | $306.93K | 99.7% | -16.0% |
| Europe [Member] | $1.44K | $2.84K | $2.32K | $1.84K | $351 | $394 | $732 | $1.38K | $536 | $1.04K | $1.41K | $1.66K | 0.3% | +310.5% |
From the segment and revenue-disaggregation notes of Vycor Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.